Bank of New York Mellon’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.6M | Buy |
|
|||||
|
2025
Q2 | $9.95M | Buy |
|
|||||
|
2025
Q1 | $11.6M | Sell |
|
|||||
|
2024
Q4 | $17.6M | Buy |
|
|||||
|
2024
Q3 | $15.9M | Sell |
|
|||||
|
2024
Q2 | $17.3M | Buy |
|
|||||
|
2024
Q1 | $13.9M | Sell |
|
|||||
|
2023
Q4 | $11.7M | Sell |
|
|||||
|
2023
Q3 | $14.6M | Buy |
|
|||||
|
2023
Q2 | $8.35M | Buy |
|
|||||
|
2023
Q1 | $6.79M | Buy |
|
|||||
|
2022
Q4 | $6.44M | Buy |
|
|||||
|
2022
Q3 | $6.71M | Buy |
|
|||||
|
2022
Q2 | $6.18M | Buy |
|
|||||
|
2022
Q1 | $6.96M | Sell |
|
|||||
|
2021
Q4 | $9.16M | Buy |
|
|||||
|
2021
Q3 | $6.37M | Buy |
|
|||||
|
2021
Q2 | $5.51M | Buy |
|
|||||
|
2021
Q1 | $4.38M | Buy |
|
|||||
|
2020
Q4 | $3.85M | Buy |
|
|||||
|
2020
Q3 | $2.78M | Sell |
|
|||||
|
2020
Q2 | $3.25M | Buy |
|
|||||
|
2020
Q1 | $529K | Buy |
|
|||||
|
2019
Q4 | $899K | Buy |
|
|||||
|
2019
Q3 | $521K | Sell |
|
|||||
|
2019
Q2 | $964K | Buy |
|
|||||
|
2019
Q1 | $591K | Buy |
|
|||||
|
2018
Q4 | $695K | Buy |
|
|||||
|
2018
Q3 | $453K | Buy |
|